Epigenetic silencing of tumor suppressor Par-4 promotes chemoresistance in recurrent breast cancer.
Ontology highlight
ABSTRACT: Tumor relapse is the leading cause of death in breast cancer, largely due to the fact that recurrent tumors are frequently resistant to chemotherapy. We previously reported that downregulation of the proapoptotic protein Par-4 promotes tumor recurrence in genetically engineered mouse models of breast cancer recurrence. In the present study, we examined the mechanism and functional significance of Par-4 downregulation in recurrent tumors. We found that epithelial-to-mesenchymal transition (EMT) promotes epigenetic silencing of Par-4 in recurrent tumors. Par-4 silencing proceeded through binding of the EMT transcription factor Twist to the Par-4 promoter, where Twist induced a unique bivalent chromatin domain. This bivalent configuration conferred plasticity at the Par-4 promoter, and Par-4
SUBMITTER: Mabe NW
PROVIDER: S-EPMC6159989 | biostudies-literature | 2018 Oct
REPOSITORIES: biostudies-literature
ACCESS DATA